SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898432-06-000691
Filing Date
2006-08-08
Accepted
2006-08-08 12:38:00
Documents
1
Period of Report
2006-08-02

Document Format Files

Seq Description Document Type Size
1 kimberlin-qubit_4ex.html 4  
1 kimberlin-qubit_4ex.xml 4 6937
  Complete submission text file 0000898432-06-000691.txt   9277
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Issuer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 535 MADISON AVENUE 18TH FLOOR NEW YORK NY 10022
Business Address 212-326-9200
Fogelman Alan (Reporting) CIK: 0001336071 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-18006 | Film No.: 061012016

Mailing Address 535 MADISON AVENUE 18TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE 18TH FLOOR NEW YORK NY 10022 212-326-9200
QUBIT HOLDINGS LLC (Reporting) CIK: 0001336153 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-18006 | Film No.: 061012017